Thu, Jul 10, 2014, 1:36 PM EDT - U.S. Markets close in 2 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • greatdayforinvestments greatdayforinvestments May 8, 2013 5:07 PM Flag

    Generic lawsuit will be over this fall! Avanir is confident then will prevail and is spending

    what is necessary to prevail... only 6 more months to go until Judge Stark rules!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I read about the lawsuit in the 10Q and see that there can not be a ruling against Avanir before October 2013 and is seems Watson has dropped out (gave their rights to another company). Does anyone else see it this way?
      Tom

    • I went to the courts web site and found that Avanir asked for a stay until the court rules on their motion to strike, the stay was granted March 19, 2013 but there didn't seem to be date set for the motion to strike ruling. Not a good web site. I couldn't find minutes or briefs for this case 11-704. Where does one get this ruling in six months?
      Tom

      • 1 Reply to tevanj
      • Judge Leonard P. Stark recently considered plaintiffs' emergency motion to stay the date for service of plaintiffs' responsive expert reports pending resolution of plaintiffs' motion to strike defendants' untimely invalidity contentions. Avanir Pharms., Inc. v. Actavis South Atlantic LLC, C.A. No. 11-704-LPS (Consol.) (D. Del. Mar. 19, 2013). Judge Stark granted plaintiffs' motion finding that plaintiffs "would be unfairly prejudiced by having to prepare and serve responsive expert reports while their motion to strike is pending, as they would not know whether it is necessary to respond to all of the opinions expressed in Defendants' expert reports." Id. at 3.

        N Worx!

        Sentiment: Strong Buy

    • Does anyone have the facts and just the facts please about this lawsuit? Like where is it filed, who is the plaintiff, case number?
      Tom

      • 2 Replies to tevanj
      • tevanj, I put up a link to some previous posts. Case # is 11-704-LPS

      • The patents-in-suit are U.S. Patent Numbers 7,659,282 and RE38,115.

        Four ANDA - SHORT desperate attempts.

        All four suits were consolidated in September and are still pending in Delaware federal cour

        Avanir claims Watson’s ANDA violates two patents covering Nuedexta, U.S. Patent Numbers 7,659,282 and RE38,115. Avanir is the assignee of the ‘282 patent and has an exclusive license for the rights to the ‘115 patent, which is assigned to co-plaintiff Center for Neurologic Study, according to the suit.

        suits against Actavis Inc. and Par Pharmaceutical Inc. in Delaware on Aug. 10

        Similar suits by Wockhardt Ltd. and Impax Laboratories Inc. followed on Aug. 29.
        All four suits were consolidated in September and are still pending in Delaware federal court.

        Sentiment: Strong Buy

    • I think they said coming to a conclusion. Maybe they mean finishing presenting arguments around December.
      To be conservative would expect a decision no earlier than January.

 
AVNR
5.68+0.13(+2.34%)1:35 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.